Bharat Biotech concludes Final Analysis for COVAXIN
Hyderabad: Bharat Biotech, a global leader in vaccine development and innovation, announced on Saturday safety and efficacy analysis data from Phase III clinical trials of COVAXIN®, a whole virion inactivated vaccine against SARS-CoV2, was!-->…